MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Altitude Marketing
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Copernicus Group IRB Collaborates with Duke, DIA to Lead Global Clinical Trial Conference - In collaboration with the Drug Information Association (DIA) and the Duke Clinical Research (DCRI) ,CGIRB led May 15’s “Creating a Global Clinical Trial Platform: Partnering for Synergy” symposium
Copernicus Group IRB Collaborates with Duke, DIA to Lead Global Clinical Trial Conference

 

NewswireToday - /newswire/ - Emmaus, PA, United States, 2012/05/30 - In collaboration with the Drug Information Association (DIA) and the Duke Clinical Research (DCRI) ,CGIRB led May 15’s “Creating a Global Clinical Trial Platform: Partnering for Synergy” symposium.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Copernicus Group IRB (CGIRB), a leading independent institutional review board, led May 15’s “Creating a Global Clinical Trial Platform: Partnering for Synergy” symposium in collaboration with the Drug Information Association (DIA) and the Duke Clinical Research Institute (DCRI).

In addition to CGIRB staff members, speakers included representatives from top academic institutions Yale, Harvard and Duke, industry-leading corporations Merck, Sanofi and Celgene, and the Food and Drug Administration (FDA).

“The symposium attracted a unique group of panelists,” said CGIRB Vice President and Chief Business Development Officer Bill Van Nostrand. “For me, as a member of the program committee, it was a remarkable experience to work with the panelists and refine the theme for each session. The blending of unique experiences and perspectives enhanced the overarching theme of collaboration.”

Yvonne Higgins, CGIRB’s Director of Quality Management, served as the symposium’s committee co-chairperson. She was instrumental in building the event’s roster of world-renowned speakers.

“It was inspiring to work with each of the panelists,” said Higgins, who also moderated a panel discussion on investigator certification, accreditation of human research protection programs HRPPs and qualification standards Phase 1 clinics. “Having a group with this much experience from so many respected organizations created a platform for innovation and new ideas to be shared.

The symposium’s question and answer sections were particularly stimulating. Attendees posed questions about the hurdles they face in conducting multi-regional clinical trials; and the expert panelists offered advice and solutions which created an exciting atmosphere of partnership.”

About Copernicus Group IRB
Experience and innovation in ethical review®
Copernicus Group IRB (cgirb.com), established in July 1996, is a leading U.S. independent institutional review board (“IRB”) dedicated to ensuring the rights and welfare of research study participants. The IRB provides ethical review of research protocols, investigators, and subject information and consent forms to ensure compliance with federal regulations set forth in 21 CFR, 45 CFR and ICH/GCP Guidelines. CGIRB achieved full AAHRPP accreditation in 2004, reaccreditation in 2007 and 2011, and ISO 9001:2008 certification in 2010.

About the Drug Information Association (DIA)

The Drug information Association (diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and wellbeing worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India and Beijing, China.

About Duke Clinical Research Institute (DCRI)

The Duke Clinical Research Institute (dcri.org), the world’s largest academic clinical research organization, is known for conducting groundbreaking multinational clinical trials, managing major national patient registries, and performing landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Altitude Marketing

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Copernicus Group IRB Collaborates with Duke, DIA to Lead Global Clinical Trial Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Gwen Hoover - AltitudeMarketing.com 
610-421-8601 gwen[.]altitudemarketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Altitude Marketing securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Altitude Marketing / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan
Inkwood Research Publishes Global Genetic Testing Market Forecast 2019-2027
NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
Alopecia Hair Loss Treatment Market is Advancing At A CAGR of 5.51% by 2027 According to Inkwood Research
Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data
South Carolina Life Sciences Industry Honors USC’s Dr. Harris Pastides, AVX Corporation
Neurodegenerative Disorder Therapeutics Market Sees a Silver Lining with Cell and Gene Therapies Finds Frost & Sullivan
Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs
The Global Postpartum Hemorrhage Treatment Device Market is Estimated to Grow At 5.10% CAGR by 2027 Finds Inkwood Research
Digital Health to Empower Women and Aging Population with mHealth, Telemedicine, Femtech and AI Finds Frost & Sullivan
Technological Advancements Propels the Global Healthcare Analytics Market At 27.13% CAGR by 2027 Reports Inkwood Research
SC Life Sciences Conference to Feature J&J Innovation Leader Michal Preminger, 40 National Speakers
American Well® Applauded by Frost & Sullivan for Driving Telehealth’s Next Growth Wave with its Pioneering Strategy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)